Hematology/Oncology Fellow @UCSFCancer
San Francisco, CA
Joined September 2023
- Tweets236
- Following428
- Followers243
- Likes573
Neha Venkatesh retweeted
On Monday I told a patient with SCLC, this is the treatment plan today, but I’m hoping next week I can bring you better news from #ESMO26
👇 THIS is what we are here for!
🌟 PRACTICE CHANGING update for ES-SCLC: adding tarlatamb to maintenance durvalumab increases median OS by 58% (9mo)
🌟
Congrats to @sands_jacob and to all the DeLLphi-305 investigators!
#ESMO26 #LCSM
Neha Venkatesh retweeted
Thrilled to share updated results from JNJ-6143, the AR-BRD4 RIPTAC therapy, presented by @BGarmezy. Totally novel MOA was well tolerated, oral pill and produced significant benefit for pts (PSA90 50%, ORR 68%). P2 trial active now and more coming. Lots of potential!
Neha Venkatesh retweeted
(1/4) Here's our clinical lab’s latest work led by @MitchellBoshkos, PGY-3, evaluating how cardiometabolic factors influence response to pre-operative ADT +/- ARPI in localized HRPCa in @pcan_journal
tinyurl.com/3u8r4vf9
Neha Venkatesh retweeted
📚 Preparing for Heme/Onc boards?
Join @ABIMcert, @ASCO & @ASH_hematology for a TEC Town Hall on the Board Certification Process.
📘 Blueprints & pathways
⏱️ Study strategies
📊 ITEs & exam readiness
💬 Live Q&A
🗓 Oct 7 | 5–6 PM ET
🔗 REGISTRATION LINK: shorturl.at/7SQks
Neha Venkatesh retweeted
Great time discussing the gaps in care for prostate and kidney cancer at 2026 @OncLive Bridging the Gals for GU cancers led by @DrRanaMcKay @TDorffOnc
Kicking off 2026 OncLive Bridging the Gaps meeting for GU cancer. The inimitable Dr Crawford lays out why biomarkers for localized #prostatecancer are underutilized
ANCOGU26: Full bladder ca continuum: perioperative EV-pembro or gem-cis-durva (NIAGARA/EV-303) pre-cystectomy, then in the metastatic setting: EV-P 1L → platinum-based chemo or FGFR/HER2 directed tx if EV-P-refractory. Trials at every stage @UCSFCancer @StanfordMed
Neha Venkatesh retweeted
🚨 Happening now! Excited to co-chair the 1st Northern California Genitourinary Cancer Research Forum with #MamtaParikh 🧬
🔬 First up: prostate cancer cases expertly moderated by @mdallera @DivyaParikhMD
Terrific panel 🎯 @ivandk3 @sandysrimd
@ANCO_News @UCSFCancer @KPSCalResearch @UCD_Cancer
Neha Venkatesh retweeted
A simply brilliant meeting - #NorCalGU26 - hosted by #DrMamtaParikh & @ADESAIONCMD. Kicking off the day with a brilliant #prostatecancer session with @mdallera & @DivyaParikhMD including experts from @KPSCalResearch, @UCSFCancer, @UCD_Cancer & @StanfordCancer. Honored to deliver our perspective from the @SoCalGUResearch lens, with previous meetings (#SoCalGU24, #SoCalGU25 & #SoCalGU26) now in the books! @sandysrimd @CMitsiadesLab
Neha Venkatesh retweeted
Terrific talk from @koshkin85 @UCSFCancer on rare variants of #bladdercancer & #kidneycancer. Beautiful tables that summarize challenging-to-treat diagnoses such as #smallcell or #adenocarcinoma. @gbanna74 @DrYukselUrun @ravikanesvaran @drkomanduri
Neha Venkatesh retweeted
Our study is now published in @JAMANetworkOpen!
We mapped 436 bladder cancer clinical trials across US counties and examined associations with incidence, mortality, & social vulnerability. Among 3,145 US counties, 77.3% had no bladder cancer trials! 🧵⬇️
jamanetwork.com/journals/jam…
Neha Venkatesh retweeted
Congratulations to @koshkin85 on a wonderful and insightful talk on bladder cancer!
It was great fun hosting you—you truly won our hearts with your warmth, humility, and infectious enthusiasm. Wonderful science, engaging discussions, and lots of laughter along the way!
We missed you, @shilpaonc @samsimsal @SpiessPhilippe @montypal.Hope to have you with us next time!
@neerajaiims @Garg_H @prernachad68810 @Chitrakshi_11 @RimleeDutta @karima_oualla
#BladderCancer #UroOncology #MedicalOncology #Oncology
Neha Venkatesh retweeted
Coming out of fellowship, there are many things I wish I had known when I started.
In our latest @ASCO Connection article, Stephanie Haddad, Charbel Matar, and I share practical lessons on navigating Heme/Onc fellowship: managing consults, finding mentors, getting started in research, and making the most of training.
📚 Fellowship 101: A Survival Guide for New Hematology/Oncology Fellows
connection.asco.org/do/fello…
#ASCOConnection #Medtwitter #Onctwitter
@HemOncFellows @Charbel_matar1 @DrSAHaddad @ASCOTECAG @oncodaily @OncLive @OncBrothers @TheFellowOnCall @TwoOncDocs @ONCOassist @IMG_Oncologists
Neha Venkatesh retweeted
An amazing week at the @ASCO @AACR Clinical Trial Workshop in Vail! Very grateful for the opportunity to learn from exceptional mentors (@ERPlimackMD), connect with old and new friends, and meet so many talented colleagues. Looking forward to putting these lessons into practice!
Grateful for an incredible experience at @ASCO @AACR Clinical Trial Workshop! It was a privilege to learn from outstanding mentors, reconnect with co-fellows from past conferences, and meet new collaborators. @kor_shah @HersheyDudipala @KalantriShreyas @ja_ocejo @ERPlimackMD
Grateful for an incredible experience at @ASCO @AACR Clinical Trial Workshop! It was a privilege to learn from outstanding mentors, reconnect with co-fellows from past conferences, and meet new collaborators. @kor_shah @HersheyDudipala @KalantriShreyas @ja_ocejo @ERPlimackMD
Neha Venkatesh retweeted
A message to @NazliDizman:
Today you will graduate from your #oncology fellowship at @UTMDAnderson. The picture below is from the 2016 @myESMO meeting in Copenhagen just after you started with my group at @cityofhope. You were my first postdoctoral fellow, and honestly, I didn't know what the heck I was doing when it came to mentoring you. The fortunate thing is you were a self starter & made my job incredibly easy, paving a clear path not just for yourself but for the trainees that came after. It's been a joy to see all that you have accomplished - publishing in @NatureMedicine, @TheLancetOncol, @JCO_ASCO & other top tier journals, getting amazing young investigator grants from @ASCO, @KidneyCancer & more & racking up more @ConquerCancerFd Merit Awards than any other trainee in recent memory (maybe tied with @crisbergerot?). Along the way, you've kept a humility & kindness about you that is unmatched, always willing to lend a hand to your junior colleagues. Your road has not been an easy one, coming from tumultuous times abroad to @cityofhope, then to @YaleIMed and then to @UTMDAnderson, but this arduous road has equipped you well for your first faculty position at @DanaFarber. I am so proud to see you join a group of oncology luminaries at @Harvard (@DrChoueiri, @KimmieNgMD, @stolaney1, @mishabeltran & so many others!!) - I am confident your stellar trajectory will continue further with their support. Enjoy Boston and know that you will always have support & good vibes coming from the west coast.
All the best,
#WorkDad
Neha Venkatesh retweeted
What an absolute honor to chair the papillary RCC Education Session at #ASCO26! 🙌🔬
Papillary renal cell carcinoma is a disease that demands our attention, and this session covered the full spectrum 🧬 — biology ➡️ frontline ➡️ refractory disease.
I was thrilled to review subsequent lines + novel therapeutic approaches for refractory papillary RCC 💉💙, including the emerging strategies and clinical trial opportunities that give me so much hope for our patients. 🌟
Huge thanks to my incredible co-faculty Dr. Ramaprasad Srinivasan 🧠 & @charlesbnguyen for such an engaging discussion — collaboration like this is what moves the field forward! 🚀
#KidneyCancer #RCC #GUOncology @ASCO @urotoday @JCO_ASCO @ASCOPost @charlesbnguyen @OncoAlert @UCSF
Neha Venkatesh retweeted
Congrats to Dr Armstrong and colleagues for CHAMP study showing quadruplet chemo immunotherapy results in much better outcomes for patients with AVPC and teNEPC - need more trials for these most aggressive #prostatecancer #ASCO26
Neha Venkatesh retweeted
#ASCO26
The PROTEUS trial results are now online...buckle up as we wait to see the full presentation. This is going to be a trial that is likely highly controversial until the full results are published.
Some may call this a homerun, others may call this the largest negative trial @ASCO 2026. Up to you to interpret!
@urotoday @EricTopol @DrChoueiri @neerajaiims @ASCO @US_FDA @NCCN @myESMO @ASTRO_org @PCF_Science @declangmurphy @mcuban
